In Q4 2017, ISR surveyed sponsors who outsource small molecule API and small molecule drug product manufacturing to inquire about their company’s main driver for working with contract manufacturers. The data show that more than half of respondents reported engaging CMOs to supplement internal manufacturing capacity. To learn more, follow the links to the Small Molecule API and the Small Molecule Drug Product report previews.

Originally published at Pharmaceutical Online.

View File